Disordered nocturnal prolactin regulation in women with breast cancer.
Mean 24-hr prolactin concentrations were determined in 25 female control subjects, 16 women with benign breast masses, and 23 subjects with breast cancer. This evaluation performed before breast surgery revealed significantly decreased (p less than 0.02) nocturnal (12 a.m. to 7 a.m.) prolactin concentrations in 12 postmenopausal breast cancer subjects that contrasted with significantly increased (p less than 0.05) nocturnal prolactin levels in five luteal-phase premenopausal women with breast cancers. Prolactin concentrations in patients with benign breast disease were not significantly different from control subjects. Two of the premenopausal breast cancer patients had marked preoperative elevations in their mean 24-hr prolactin levels, and they were two of the three subjects who have since expired. Nocturnal prolactin secretion was significantly decreased (p less than 0.03) in four premenopausal breast cancer patients when they were studied 1 year after surgery; however, it remained the same in the eight postmenopausal breast cancer patients similarly evaluated. Although disordered prolactin regulation has been found in these women with breast cancer, its role in the etiology and progression of human cancer is still uncertain.
D000328:Adult; D001943:Breast Neoplasms / Q000097:blood / Q000503:physiopathology* / Q000601:surgery; D002369:Castration; D002940:Circadian Rhythm; D005260:Female; D005498:Follicular Phase; D006801:Humans; D008183:Luteal Phase; D008593:Menopause; D008875:Middle Aged; D011388:Prolactin / Q000097:blood* / Q000378:metabolism
D011388:Prolactin